NextCure (NXTC) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free NXTC Stock Alerts $1.66 +0.07 (+4.40%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability NextCure Short Interest DataCurrent Short Volume112,400 sharesPrevious Short Volume113,200 sharesChange Vs. Previous Month-0.71%Dollar Volume Sold Short$136,004.00Short Interest Ratio / Days to Cover0.4Last Record DateApril 30, 2024Outstanding Shares27,970,000 sharesFloat Size21,150,000 sharesShort Percent of Float0.53%Today's Trading Volume77,197 sharesAverage Trading Volume219,337 sharesToday's Volume Vs. Average35% Short Selling NextCure ? Sign up to receive the latest short interest report for NextCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNXTC Short Interest Over TimeNXTC Days to Cover Over TimeNXTC Percentage of Float Shorted Over Time Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth NextCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024112,400 shares $136,004.00 -0.7%0.5%0.4 $1.21 4/15/2024113,200 shares $189,044.00 -88.6%0.5%0.4 $1.67 3/31/2024993,800 shares $2.22 million +18.4%4.7%3.8 $2.23 3/15/2024839,700 shares $1.22 million +579.9%4.0%3.7 $1.45 2/29/2024123,500 shares $213,655.00 +4.7%0.6%0.7 $1.73 2/15/2024118,000 shares $166,380.00 +8.4%0.6%1.1 $1.41 Get the Latest News and Ratings for NXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NextCure and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024108,900 shares $132,858.00 -11.8%0.6%1.2 $1.22 1/15/2024123,400 shares $143,144.00 -42.8%0.6%1.3 $1.16 12/31/2023215,800 shares $246,012.00 -6.2%1.1%2.2 $1.14 12/15/2023230,000 shares $255,300.00 +17.3%1.2%2.3 $1.11 11/30/2023196,100 shares $231,398.00 -0.6%1.0%3.2 $1.18 11/15/2023197,200 shares $246,500.00 +0.1%1.0%3.7 $1.25 10/31/2023197,000 shares $202,910.00 -1.5%1.0%3.7 $1.03 10/15/2023199,900 shares $249,875.00 -13.2%1.0%4.7 $1.25 9/30/2023230,300 shares $297,087.00 +11.9%1.2%6.4 $1.29 9/15/2023205,900 shares $284,142.00 -2.5%1.1%4.8 $1.38 8/31/2023211,100 shares $308,206.00 +0.3%1.1%5.2 $1.46 8/15/2023210,500 shares $357,850.00 -1.5%1.1%4.8 $1.70 7/31/2023213,800 shares $367,736.00 -3.5%1.1%4.2 $1.72 7/15/2023221,600 shares $390,016.00 -17.9%1.1%4.1 $1.76 6/30/2023269,800 shares $485,640.00 +7.2%1.4%4.7 $1.80 6/15/2023251,700 shares $420,339.00 +6.6%1.3%4.7 $1.67 5/31/2023236,100 shares $406,092.00 -12.2%1.2%3.9 $1.72 5/15/2023268,900 shares $457,856.03 +4.3%1.4%3.8 $1.70 4/30/2023257,800 shares $389,278.00 -4.1%1.3%3.4 $1.51 4/15/2023268,700 shares $403,050.00 -15.4%1.4%3.2 $1.50 3/31/2023317,700 shares $470,196.00 -3.8%1.6%3.5 $1.48 3/15/2023330,300 shares $518,571.00 -6.9%1.7%2.1 $1.57 2/28/2023354,900 shares $550,095.00 +14.7%1.8%2.1 $1.55 2/15/2023309,500 shares $485,915.00 -7.3%1.6%1.7 $1.57 1/31/2023333,900 shares $557,613.00 -0.2%1.9%1.7 $1.67 1/15/2023334,700 shares $538,867.00 -9.5%1.9%1.7 $1.61 12/30/2022369,800 shares $521,418.00 -12.5%2.1%1.9 $1.41 12/15/2022422,600 shares $549,380.00 +3.4%2.4%2.5 $1.30 11/30/2022408,600 shares $576,126.00 -4.3%2.3%3.5 $1.41 11/15/2022426,800 shares $708,488.00 -10.2%2.4%4 $1.66 10/31/2022475,300 shares $1.19 million -11.6%2.7%4.1 $2.50 10/15/2022537,400 shares $1.45 million -8.6%3.3%5.4 $2.70 9/30/2022587,800 shares $1.62 million -3.2%3.6%5.5 $2.75 9/15/2022607,100 shares $2.31 million -21.6%3.7%4.8 $3.81Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NXTC Short Interest - Frequently Asked Questions What is NextCure's current short interest? Short interest is the volume of NextCure shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 112,400 shares of NXTC short. 0.53% of NextCure's shares are currently sold short. Learn More on NextCure's current short interest. What is a good short interest percentage for NextCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of NextCure's floating shares are currently sold short. Is NextCure's short interest increasing or decreasing? NextCure saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 112,400 shares, a decrease of 0.7% from the previous total of 113,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NextCure's float size? NextCure currently has issued a total of 27,970,000 shares. Some of NextCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NextCure currently has a public float of 21,150,000 shares. How does NextCure's short interest compare to its competitors? 0.53% of NextCure's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NextCure: Ocuphire Pharma, Inc. (4.71%), HCW Biologics Inc. (0.05%), Aadi Bioscience, Inc. (6.50%), Gain Therapeutics, Inc. (1.02%), Eyenovia, Inc. (12.11%), CASI Pharmaceuticals, Inc. (0.73%), VYNE Therapeutics Inc. (0.68%), Immuneering Co. (15.37%), Unicycive Therapeutics, Inc. (2.13%), Xilio Therapeutics, Inc. (5.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short NextCure stock? Short selling NXTC is an investing strategy that aims to generate trading profit from NextCure as its price is falling. NXTC shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NextCure? A short squeeze for NextCure occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NXTC, which in turn drives the price of the stock up even further. How often is NextCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXTC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Ocuphire Pharma Short Interest Data HCW Biologics Short Interest Data Aadi Bioscience Short Interest Data Gain Therapeutics Short Interest Data Eyenovia Short Interest Data CASI Pharmaceuticals Short Interest Data VYNE Therapeutics Short Interest Data Immuneering Short Interest Data Unicycive Therapeutics Short Interest Data Xilio Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NXTC) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersHow to Play the AI and Crypto Markets in One SwingWeiss RatingsAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing